Niagen Bioscience, Inc. (NAGE)

Market Cap	1.01B
Revenue (ttm)	107.93M
Net Income (ttm)	14.11M
Shares Out	78.94M
EPS (ttm)	0.18
PE Ratio	71.58
Forward PE	118.28
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,760,433
Open	14.40
Previous Close	14.41
Day's Range	12.64 - 14.40
52-Week Range	2.41 - 14.69
Beta	2.08
Analysts	Strong Buy
Price Target	16.67 (+30.13%)
Earnings Date	Aug 6, 2025

About NAGE

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+) test kits to healthcare practitioners; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and ph...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1999
• Employees: 104
• Stock Exchange: NASDAQ
• Ticker Symbol: NAGE
• Website: https://www.niagenbioscience.com

Analyst Summary

According to 3 analysts, the average rating for NAGE stock is "Strong Buy." The 12-month stock price target is $16.67, which is an increase of 30.13% from the latest price.

Price Target

$16.67

(30.13% upside)

Analyst Consensus: Strong Buy